您要查找的是不是:
- The recombinant human urinary plasminogen activator (RHU-PA) is a thrombolytic agent. 重组人糖基化尿型纤溶酶原激活剂(RHU-PA)是一种溶血栓药物。
- Recombinant human urinary plasminogen activator 重组人糖基化尿型纤溶酶原激活剂
- urinary plasminogen activator ( uPA ) 尿激酶型纤溶酶原激活物
- Keywords Osteosarcoma/ pathology;Urinary plasminogen activator;Gene expression; 骨肉瘤;尿纤溶酶原激活物;基因表达;
- Keywords streptokinase;urinary plasminogen activator;venous thrombosis;thrombolytic therapy; 链激酶;尿纤溶酶原激活物;静脉血栓形成;血栓溶解疗法;
- Keywords breast neoplasms/pathology;cadherins;antigens;CD44;urinary plasminogen activator;immunohistochemistry; 乳腺肿瘤/病理学;钙粘着糖蛋白类;抗原;CD44;尿纤溶酶原激活物;免疫组织化学;
- Keywords Giant cell tumor;bone;Urinary plasminogen activator;Signal transduction; 巨细胞瘤;骨;尿纤溶酶原激活物;信号转导;
- urinary plasminogen activator 尿纤溶酶原激活物
- Urinary type plasminogen activator 尿激酶型纤溶酶原激活物
- THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN ORAL SQUAMOUS CELL CARCINOMA. 尿激酶受体在口腔鳞癌中的表达。
- Urinary Plasminogen Activator/metabolism/genetics 尿纤溶酶原激活物/代谢/遗传学
- Recombinant tissue-type plasminogen activator (r-TPA) was also used when clinically indicated. 临床上有指征时也可应用重组组织型纤溶酶原激活剂。
- Urinary Plasminogen Activator/therapeutic use 尿纤溶酶原激活物/治疗应用
- In this process, urokinase-type plasminogen activator(uPA) and P-selectin play a very important role . 在此过程中,尿激酶型纤溶酶原激活物(urokinase-type plasminogen activator,uPA)和P-选择素起着十分重要的作用。
- PURPOSE:To establish a stable cell strain secreted recombinant tissue-type plasminogen activator(rt-PA). 目的:建立稳定表达人组织型纤溶酶原激活剂(tissue-type plasminogen activatort-PA)的细胞系。
- Enzymatic Vitreolysis with Recombinant Microplasminogen and Tissue Plasminogen Activator. Chen W(陈武); Huang X; Ma XW; et al.
- Objective:To examine whether VLDL or LDL can stimulate the secretion of plasminogen activator inhibitor type 1 (PAI-1) in hepatic cells. 目的 :观察极低密度脂蛋白 (VL DL)与低密度脂蛋白 (L DL)是否能刺激肝细胞纤溶酶原激活物抑制物 - 1(PAI- 1)的分泌。
- Hacke W, Kaste M, Fieschi C. Intrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA, 1995, 247 (13):1017. 郑家生;崔雄伟;赵永春;等.;急性缺血性脑卒中超选择动脉溶栓疗法的并发症分析
- BAL b/c mice were immunized by injections of human tissue-type plasminogen activator (t-PA) purified from human melanoma cells and pig heart. 用猪心t-PA和人黑色素瘤细胞分泌的t-PA作抗原,经腹腔及脾内免疫Bal b/c小鼠。
- Objective To investigate the anticoagulative and fibrinolytic effects of lumbrokinase and their relation to tissue plasminogen activator (t-PA). 目的探讨蚓激酶抗凝、纤溶机制及其与组织型纤溶酶原激活剂(t-PA)的关系。